Navigation Links
Two Pharmaceutical Executives Join TheraQuest Management Team
Date:6/24/2010

BLUE BELL, Pa., June 24 /PRNewswire/ -- TheraQuest Biosciences, Inc., a clinical stage pain management company today announced the appointment of Dr. Danny Kao, PhD, JD, as Senior Vice President, Pharmaceutical Development and General Counsel and Douglas R. Baum, MS as Senior Vice President, Business Development. On June 22, 2010, TheraQuest unveiled its analgesic product pipeline and provided a status update on its lead programs in chronic pain and neuropathic pain.

Dr. Najib Babul, CEO, said, "We have added two seasoned executives with more than 30 years of combined analgesic drug development experience to our senior management team.  The addition of outstanding, multi-talented pharma executives like Danny and Doug is a key step in TheraQuest's evolution as a company. Combined with our new product line-up, this move positions TheraQuest for significant progress in near future."

Biographical Summary of Management Team Additions

Danny Kao, PhD, JD joins TheraQuest as Senior Vice President, Pharmaceutical Development and General Counsel. Previously, Dr. Kao was Director, Strategic Development and Director, Formulation Development at Endo Pharmaceuticals.  Dr. Kao has developed several extended release dosage forms, including first to file generic formulations bioequivalent to OxyContin® and MS Contin®.  Dr. Kao received his master's degree in industrial pharmacy from the St. John's University, New York, his PhD in pharmaceutical sciences from the University of Kentucky and his JD from Touro College Law Center. Dr. Kao is a registered patent attorney at the USPTO and is admitted to practice law in New York and New Jersey.

Douglas R. Baum, MS joins TheraQuest as Senior Vice President, Business Development. Mr. Baum has been involved in analgesic drug development for over 20 years with SCIREX Corporation and with its new corporate entity, Premier Research Group.  He has extensive business development experience, working across a number of classes and formulations of analgesics. Mr. Baum served as VP, Strategic Development in the Analgesia & Rheumatology at SCIREX and later as Senior VP, Early Development Unit and VP, Global Business Development at Premier Research. He has significant operational experience with P&L responsibility, having served as Project Director and Program Director in analgesia. Mr. Baum has authored over 20 scientific publications in the field of pain. He received his bachelor's and master's degree from the University of Texas at Austin.


'/>"/>
SOURCE TheraQuest Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy
2. Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc.
3. K-V Pharmaceutical Company Announces the Nomination and Appointment of New Independent Member to the Board of Directors
4. Pharmaceutical Market Research: A Strategic Business Partner in 2011
5. Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
6. Effective Social Media Marketing Strategies for Pharmaceutical Market (2010 - 2015): MarketsandMarkets
7. CSafe Signs Master Lease With Cathay Pacific Airways to Further Enhance Healthcare and Pharmaceutical Transport
8. Isis Pharmaceuticals to Present at The Wells Fargo 2010 Healthcare Conference
9. Obamas Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets (Pharmaceuticals, Medical Devices and Health Insurance)
10. Pharmaceutical and Biotech Executives Must Manage and Optimize Key Opinion Leaders or Fall Behind in the Marketplace
11. Onyx Pharmaceuticals Presents Interim Results of Phase 1b Carfilzomib Combination Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017 Abdominal Aortic Aneurysm Repair Devices Market was ... 2022, Globally, registering a CAGR of 5.1% from 2016 to 2022. The endovascular stent ... dominate the market during the study period. Continue Reading ... ... ...
(Date:3/24/2017)... 2017 New England Pediatric Device Consortium (NEPDC) ... including funding and in-kind service towards the commercialization of ... "Making blood draws less traumatic for children could ... experience better.  We,re looking forward to working with Velano ... care for the kids we treat," said Ann-Christine ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global Wound ... report to their offering. ... The global wound care market was worth $24,482.9 million in 2015 and ... Among the various wound care products type, the advanced wound ... 2015. Among the various applications, surgical wound segment held the largest share ...
Breaking Medicine Technology:
(Date:3/25/2017)... ... 2017 , ... Getting earned media coverage meaningful for Garden Media Group's clients ... the year, Garden Media aims to provide material helpful to clients’ goals and bottom ... client’s key messages to gain coveted media placements, Garden Media wows clients year-round. ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... from third world countries to hospitals in the United States, it’s a threat ... on the current obstacles facing infection prevention and offers strategies for the healthcare ...
(Date:3/24/2017)... ... ... The iaedp Foundation, the premier provider of educational programs and training standards for eating ... of disordered eating, announced today that the 2017 Symposium set a new attendance record ... countries converged on the Green Valley Resort in Las Vegas. , “We are ...
(Date:3/24/2017)... ... 24, 2017 , ... Northridge dentists, Dr. Michel ... sleep apnea and TMJ at their office. TMJ, or temporomandibular joint disorder, has ... type, is increasingly being treated at dental offices with newly developed procedures and ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located ... training and leads programs. , In February, 2017, Empower Brokerage introduced their new ... Partners is designed to teach how to maximize their sales efforts, as well ...
Breaking Medicine News(10 mins):